These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36683600)

  • 1. Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1.
    Sun WP; Du X; Chen JJ
    Int J Clin Pract; 2022; 2022():6926510. PubMed ID: 36683600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
    Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
    Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.
    Badoz M; Serzian G; Favoulet B; Sellal JM; De Chillou C; Hammache N; Laurent G; Mebazaa A; Ecarnot F; Bardonnet K; Seronde MF; Schiele F; Meneveau N
    J Am Heart Assoc; 2021 Jul; 10(13):e020917. PubMed ID: 34187182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure.
    Chen C; Qu X; Gao Z; Zheng G; Wang Y; Chen X; Li H; Huang W; Zhou H
    Int Heart J; 2018 Jan; 59(1):58-63. PubMed ID: 29279523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.
    Wang Z; Cheng L; Zhang J; Liang Z; Dong R; Hang F; Wang X; Wang Z; Wu Y; Du J
    Med Sci Monit; 2020 Sep; 26():e926221. PubMed ID: 32898129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated soluble ST2 concentration may involve in the progression of atrial fibrillation.
    Ma X; Yuan H; Luan HX; Shi YL; Zeng XL; Wang Y
    Clin Chim Acta; 2018 May; 480():138-142. PubMed ID: 29428199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation.
    Krittayaphong R; Pumprueg S; Sairat P
    Clin Cardiol; 2022 Apr; 45(4):447-456. PubMed ID: 35188278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation.
    García-Seara J; González Melchor L; Rodríguez García J; Gude F; Martínez Sande JL; Rodríguez Mañero M; Fernández López XA; Minguito Carazo C; González Ferrero T; Eiras S; Lage R; Moscoso I; Bandín SF; Lago F; Alvarez E; Alvarez CV; González Juanatey JR
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.
    Kalogeropoulos AS; Tsiodras S; Rigopoulos AG; Sakadakis EA; Triantafyllis A; Kremastinos DT; Rizos I
    BMC Cardiovasc Disord; 2011 Dec; 11():77. PubMed ID: 22204652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Laboratory Biomarkers in Paroxysmal Atrial Fibrillation: A Single Center Cross-Sectional Study.
    Sun W; Li H; Wang Z; Wu Y; Du J
    Contrast Media Mol Imaging; 2022; 2022():7012377. PubMed ID: 35845733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Nortamo S; Ukkola O; Lepojärvi S; Kenttä T; Kiviniemi A; Junttila J; Huikuri H; Perkiömäki J
    Int J Cardiol; 2017 Dec; 248():173-178. PubMed ID: 28942872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of soluble suppression of tumourigenicity 2 and galectin-3 for sinus rhythm maintenance after cardioversion due to persistent atrial fibrillation in patients with normal left ventricular systolic function.
    Wałek P; Gorczyca I; Grabowska U; Spałek M; Wożakowska-Kapłon B
    Europace; 2020 Oct; 22(10):1470-1479. PubMed ID: 32754725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.
    Wakula P; Neumann B; Kienemund J; Thon-Gutschi E; Stojakovic T; Manninger M; Scherr D; Scharnagl H; Kapl M; Pieske B; Heinzel FR
    Europace; 2017 Apr; 19(4):544-551. PubMed ID: 28431065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.
    Tan R; Yu H; Han X; Liu Y; Yang X; Xia YL; Yin X
    Front Cardiovasc Med; 2021; 8():653312. PubMed ID: 34222362
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
    Wachter R; Lahno R; Haase B; Weber-Krüger M; Seegers J; Edelmann F; Wohlfahrt J; Gelbrich G; Görlitz A; Kermer P; Vollmann D; Hasenfuß G; Gröschel K; Stahrenberg R
    PLoS One; 2012; 7(4):e34351. PubMed ID: 22509292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
    Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
    Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.
    Jin XL; Huang N; Shang H; Zhou MC; Hong Y; Cai WZ; Huang J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28719009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation.
    Degener S; Pattberg SV; Feuersenger H; Bansmann PM; Shin DI; Krummenauer F; Horlitz M
    J Interv Card Electrophysiol; 2011 Apr; 30(3):217-25. PubMed ID: 21249437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.